Recombinant Influenza A Virus Hemagglutinin H3 protein (ab69750)

Overview

Description

  • NatureRecombinant
  • SourceBaculovirus infected insect cells

Specifications

Our Abpromise guarantee covers the use of ab69750 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Western blot

    ELISA

  • Purity> 90 % SDS-PAGE.
    Purity is greater than 90.0% as determined by SDS-PAGE. Filter sterilised.
  • FormLiquid
  • Additional notes


    H3N2 descended from H2N2 by antigenic shift and has tended to dominate in prevalence over H1N1, H1N2, and influenza B. Both the H2N2 and H3N2 strains contained genes from avian influenza viruses.

  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Store at +4°C.

    Preservative: None
    Constituents: 0.005% Tween 20, 150mM Sodium chloride, 10mM Sodium phosphate, pH 7.4

General Info

  • RelevanceInfluenza A virus is a major public health threat. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes.

References for Recombinant Influenza A Virus Hemagglutinin H3 protein (ab69750)

ab69750 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab69750.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"